Companies Face Costly System Overhauls With New FDA Regulations
Mark E. Kolb
Advertisement
Mark E. Kolb is CEO of Taratec Development, a consulting firm that provides e-technology and regulatory solutions for the life sciences industry.
Articles by Mark E. Kolb
Advertisement
Latest Updated Articles
- The Next Y2K
Published: May 1st 2001 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
Real-World Data Brings New Insights to Natural History of Disease Studies
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5